Product Code: GVR-1-68038-570-0
Virus Filtration Market Growth & Trends:
The global virus filtration market size is expected to reach USD 11.43 billion by 2030, registering a CAGR of 13.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing demand for biological products such as vaccines, therapeutic proteins, blood and blood products, cellular and gene therapy, tissue, and stem cell products is a major factor driving the growth. Biopharmaceuticals are mainly derived from human, animal, and plants and therefore require a scrutinized virus filtration procedure to avoid virus contamination in the production. Therefore, the necessity of this procedure during the production of biologics is expected to boost the market growth.
Many leading biopharmaceuticals and biotechnology manufacturers are involved in R&D to develop innovative biological products. For instance, in 2016, Pfizer Inc. invested USD 7,872.0 million in R&D, which was around 8% more than the R&D investment in 2015. This investment was mainly made to boost innovation and productivity in R&D to accomplish a sustainable pipeline of vaccines and differentiated therapies with lucrative commercial opportunities. Virus filtration is an important step in biologics development, thus, increasing R&D on biologics is expected to drive the product demand.
Virus Filtration Market Report Highlights:
- The consumables segment dominated the virus filtration market with the largest revenue share of 53.4% in 2024. The instruments segment is expected to grow at a significant CAGR of 12.9% over the forecast period.
- The biologicals segment dominated the virus filtration market with the largest revenue share in 2024. The medical devices segment is expected to grow significantly over the forecast period.
- The biopharmaceutical and biotechnology companies led the virus filtration market with the largest revenue share in 2024. The Contract Research Organizations (CRO) sector is expected to grow at the fastest CAGR over the forecast period.
- The North America virus filtration market dominated the global market, accounting for the largest revenue share of 42.6% in 2024. The U.S. virus filtration market led the North American market with the largest revenue share in 2024.
- The Asia Pacific virus filtration market is expected to grow at the fastest CAGR of 15.0% over the forecast period.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End Use
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Virus Filtration Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
Chapter 4. Virus Filtration Market: Product Business Analysis
- 4.1. Product Market Share, 2024 & 2030
- 4.2. Product Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Consumables
- 4.4.1. Consumables Market, 2018 - 2030 (USD Million)
- 4.4.2. Kits and reagents
- 4.4.2.1. Kits and reagents Market, 2018 - 2030 (USD Million)
- 4.4.3. Others
- 4.4.3.1. Others Market, 2018 - 2030 (USD Million)
- 4.5. Instruments
- 4.5.1. Instruments Market, 2018 - 2030 (USD Million)
- 4.5.2. Filtration Systems
- 4.5.2.1. Filtration Systems Market, 2018 - 2030 (USD Million)
- 4.5.3. Chromatography Systems
- 4.5.3.1. Chromatography Systems Market, 2018 - 2030 (USD Million)
- 4.6. Services
- 4.6.1. Services Market, 2018 - 2030 (USD Million)
Chapter 5. Virus Filtration Market: Application Business Analysis
- 5.1. Application Market Share, 2024 & 2030
- 5.2. Application Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Biologicals
- 5.4.1. Virus Filtration Market, in Biologicals, 2018 - 2030 (USD Million)
- 5.4.2. Vaccines And Therapeutics
- 5.4.2.1. Virus Filtration Market, in Vaccines and Therapeutics, 2018 - 2030 (USD Million)
- 5.4.3. Blood And Blood Products
- 5.4.3.1. Virus Filtration Market, in Blood And Blood Products, 2018 - 2030 (USD Million)
- 5.4.4. Cellular And Gene Therapy Products
- 5.4.4.1. Virus Filtration Market, in Cellular And Gene Therapy Products, 2018 - 2030 (USD Million)
- 5.4.5. Tissue And Tissue Products
- 5.4.5.1. Virus Filtration Market, in Tissue And Tissue Products, 2018 - 2030 (USD Million)
- 5.4.6. Stem Cell Products
- 5.4.6.1. Virus Filtration Market, in Stem Cell Products, 2018 - 2030 (USD Million)
- 5.5. Medical Devices
- 5.5.1. Virus Filtration Market, in Medical Devices, 2018 - 2030 (USD Million)
- 5.6. Water Purification
- 5.6.1. Virus Filtration Market, in Water Purification, 2018 - 2030 (USD Million)
- 5.7. Air Purification
- 5.7.1. Virus Filtration Market, in Air Purification, 2018 - 2030 (USD Million)
Chapter 6. Virus Filtration Market: End Use Business Analysis
- 6.1. End Use Market Share, 2024 & 2030
- 6.2. End Use Segment Dashboard
- 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 6.4. Biopharmaceutical & Biotechnology Companies
- 6.4.1. Virus Filtration Market, in Biopharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
- 6.5. Contract Research Organizations
- 6.5.1. Virus Filtration Market, in Contract Research Organizations, 2018 - 2030 (USD Million)
- 6.6. Medical Device Companies
- 6.6.1. Virus Filtration Market, in Medical Device Companies, 2018 - 2030 (USD Million)
- 6.7. Academic Institutes & Research Laboratories
- 6.7.1. Virus Filtration Market, in Academic Institutes & Research Laboratories, 2018 - 2030 (USD Million)
Chapter 7. Virus Filtration Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2024 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.4. North America
- 7.4.1. North America Virus Filtration Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.4.2. U.S.
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Regulatory Framework
- 7.4.2.3. Competitive Insights
- 7.4.2.4. U.S. Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Canada
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Regulatory Framework
- 7.4.3.3. Competitive Insights
- 7.4.3.4. Canada Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. Mexico
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Regulatory Framework
- 7.4.4.3. Competitive Insights
- 7.4.4.4. Mexico Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5. Europe
- 7.5.1. Europe Virus Filtration Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.5.2. UK
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Regulatory Framework
- 7.5.2.3. Competitive Insights
- 7.5.2.4. UK Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. France
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Regulatory Framework
- 7.5.3.3. Competitive Insights
- 7.5.3.4. France Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. Italy
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Regulatory Framework
- 7.5.4.3. Competitive Insights
- 7.5.4.4. Italy Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Spain
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Regulatory Framework
- 7.5.5.3. Competitive Insights
- 7.5.5.4. Spain Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Denmark
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Regulatory Framework
- 7.5.6.3. Competitive Insights
- 7.5.6.4. Denmark Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Sweden
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Regulatory Framework
- 7.5.7.3. Competitive Insights
- 7.5.7.4. Sweden Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.8. Norway
- 7.5.8.1. Key Country Dynamics
- 7.5.8.2. Regulatory Framework
- 7.5.8.3. Competitive Insights
- 7.5.8.4. Norway Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Asia Pacific Virus Filtration Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.6.2. Japan
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Regulatory Framework
- 7.6.2.3. Competitive Insights
- 7.6.2.4. Japan Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. China
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Regulatory Framework
- 7.6.3.3. Competitive Insights
- 7.6.3.4. China Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. India
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Regulatory Framework
- 7.6.4.3. Competitive Insights
- 7.6.4.4. India Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Australia
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Regulatory Framework
- 7.6.5.3. Competitive Insights
- 7.6.5.4. Australia Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.6. Thailand
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Regulatory Framework
- 7.6.6.3. Competitive Insights
- 7.6.6.4. Thailand Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.7. South Korea
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Regulatory Framework
- 7.6.7.3. Competitive Insights
- 7.6.7.4. South Korea Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.7. Latin America
- 7.7.1. Latin America Virus Filtration Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.7.2. Brazil
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Regulatory Framework
- 7.7.2.3. Competitive Insights
- 7.7.2.4. Brazil Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Argentina
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Regulatory Framework
- 7.7.3.3. Competitive Insights
- 7.7.3.4. Argentina Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8. Middle East & Africa
- 7.8.1. Middle East & Africa Virus Filtration Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.8.2. South Africa
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Regulatory Framework
- 7.8.2.3. Competitive Insights
- 7.8.2.4. South Africa Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.3. Saudi Arabia
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Regulatory Framework
- 7.8.3.3. Competitive Insights
- 7.8.3.4. Saudi Arabia Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.4. UAE
- 7.8.4.1. Key Country Dynamics
- 7.8.4.2. Regulatory Framework
- 7.8.4.3. Competitive Insights
- 7.8.4.4. UAE Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.5. Kuwait
- 7.8.5.1. Key Country Dynamics
- 7.8.5.2. Regulatory Framework
- 7.8.5.3. Competitive Insights
- 7.8.5.4. Kuwait Virus Filtration Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Participant Overview
- 8.2. Company Market Position Analysis
- 8.3. Company Categorization
- 8.4. Strategy Mapping
- 8.5. Company Profiles/Listing
- 8.5.1. Merck KGaA
- 8.5.1.1. Overview
- 8.5.1.2. Financial Performance
- 8.5.1.3. Type Benchmarking
- 8.5.1.4. Strategic Initiatives
- 8.5.2. Danaher
- 8.5.2.1. Overview
- 8.5.2.2. Financial Performance
- 8.5.2.3. Type Benchmarking
- 8.5.2.4. Strategic Initiatives
- 8.5.3. Sartorius AG
- 8.5.3.1. Overview
- 8.5.3.2. Financial Performance
- 8.5.3.3. Type Benchmarking
- 8.5.3.4. Strategic Initiatives
- 8.5.4. Thermo Fisher Scientific Inc.
- 8.5.4.1. Overview
- 8.5.4.2. Financial Performance
- 8.5.4.3. Type Benchmarking
- 8.5.4.4. Strategic Initiatives
- 8.5.5. GE HealthCare
- 8.5.5.1. Overview
- 8.5.5.2. Financial Performance
- 8.5.5.3. Type Benchmarking
- 8.5.5.4. Strategic Initiatives
- 8.5.6. Charles River Laboratories
- 8.5.6.1. Overview
- 8.5.6.2. Financial Performance
- 8.5.6.3. Type Benchmarking
- 8.5.6.4. Strategic Initiatives
- 8.5.7. Asahi Kasei Medical Co., Ltd.
- 8.5.7.1. Overview
- 8.5.7.2. Financial Performance
- 8.5.7.3. Type Benchmarking
- 8.5.7.4. Strategic Initiatives
- 8.5.8. WuXi AppTec
- 8.5.8.1. Overview
- 8.5.8.2. Financial Performance
- 8.5.8.3. Type Benchmarking
- 8.5.8.4. Strategic Initiatives
- 8.5.9. Lonza
- 8.5.9.1. Overview
- 8.5.9.2. Financial Performance
- 8.5.9.3. Type Benchmarking
- 8.5.9.4. Strategic Initiatives
- 8.5.10. Clean Biologics
- 8.5.10.1. Overview
- 8.5.10.2. Financial Performance
- 8.5.10.3. Type Benchmarking
- 8.5.10.4. Strategic Initiatives